ESSA Pharma Inc.
EPIX
$1.74
$0.021.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -34.25% | 12.14% | 19.53% | -50.72% | -8.81% |
| Total Depreciation and Amortization | 2.63% | 0.44% | 2.25% | -3.48% | -15.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.90% | 28.37% | 73.34% | 529.69% | -74.20% |
| Change in Net Operating Assets | -237.68% | 146.88% | -165.37% | 191.31% | -559.73% |
| Cash from Operations | -92.21% | 41.41% | 15.74% | -0.46% | -51.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -118.69% | 89,365.53% | -99.96% | 659.29% | 3,211.30% |
| Cash from Investing | -118.69% | 89,365.53% | -99.96% | 659.29% | 3,211.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 133.20% | -96.02% | 227.20% | 969.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 133.20% | -96.02% | 227.20% | 1,546.32% |
| Foreign Exchange rate Adjustments | -- | 442.11% | -146.34% | 925.00% | -75.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -158.67% | 411.07% | -110.11% | 3,329.84% | 134.47% |